HealthQuest Capital led a $22m funding round in RareCyte.

Investment firm HealthQuest Capital led a $22m funding round in RareCyte, a company creating liquid and tissue biopsy analysis platforms, with participation from 5AM Ventures and company founder, Ron Seubert. "We are excited to have HealthQuest Capital lead this new funding; their team’s healthcare expertise and ecosystem will be a valuable addition to our group of active and supportive investors. This funding will allow RareCyte to accelerate our global sales and marketing efforts, fund development of applications for our new tissue multiplexing platform, and release new liquid biopsy assays," Joe Victor, RareCyte President and CEO.